Business Context and Reporting Period
This Form 6-K filing by Galmed Pharmaceuticals Ltd. is dated July 11, 2024, covering the month of July 2024. The report addresses the status of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the procedural adjournment of the Annual General Meeting originally scheduled for July 10, 2024, due to a lack of quorum.
Guidance, Outlook, and Management Commentary
Management has announced that the Annual General Meeting will be reconvened on Wednesday, July 17, 2024, at 16:00 p.m. (Israel time). The meeting will be held at the offices of Meitar Law Offices, located at 16 Abba Hillel Silver Rd., Ramat Gan, 5250608, Israel. The filing notes that its contents are incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Key Facts for Investor Verification
- The Annual General Meeting scheduled for July 10, 2024, was adjourned due to a lack of quorum.
- The reconvened meeting is scheduled for July 17, 2024, at 16:00 p.m. Israel time.
- The meeting location is Meitar Law Offices in Ramat Gan, Israel.
- This filing contains no financial performance data or updated guidance.